1st Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for AMGEN USA, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Support for biologics data exclusivity period in USMCA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAUREN B O'BRIEN | — |
Health Issues HCR
Drug pricing issues, including the IPI Drug Pricing Model, Prescription Drug Pricing Act (S. 2543), the Lower Costs, More Cures Act (S. 3129), and other congressional proposals; the CARES Act (H.R. 748) and home health options for Part B drugs; Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283).
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
| LAUREN B O'BRIEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.